Senior insider sale
Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$64.2K
10.95K shares
What this filing means
NOUGUES MAXIMO F plans to sell 10.95K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $64.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/7/2026ACC: 0001959173-26-000192
Officer· Chief Financial Officer
Since Nov 2018
10.95K
Shares to sell
$64.2K
Approx. market value
6.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/2/2026
6.41KTotal acquired6.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Restricted Stock Vesting Compensation | 6.41K | — |
| Total | 6.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.54K
Market value
$26.5K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.41K
Market value
$37.7K
1/7/2026
Total
Units
10.95K
Value
$64.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 4.54K | $26.5K | — | Completed |
| Planned — Approximate Date | ||||
1/7/2026 | 6.41K | $37.7K | NASDAQ | Planned |
| Total | 10.95K | $64.2K | ||